Duchenne muscular dystrophy (DMD) is the most frequent muscular dystrophy in children and young adults. Currently, there is no cure for the disease. The transplantation of healthy myoblasts is an experimental therapeutic strategy, since it could restore the expression of dystrophin in DMD muscles. Nevertheless, this cellular therapy is limited by immune reaction, low migration of the implanted cells, and high early cell death that could be at least partially due to anoikis. To avoid the lack of attachment of the cells to an extracellular matrix after the transplantation, which is the cause of anoikis, we tested the use of a fibrin gel for myoblast transplantation. In vitro, three concentrations of fibrinogen were compared (3, 20, and 50 mg/ ml) to form a fibrin gel. A stiffer fibrin gel leads to less degradability and less proliferation of the cells. A concentration of 3 mg/ml fibrin gel enhanced the differentiation of the myoblasts earlier as a culture in monolayer. Human myoblasts were also transplanted in muscles of Rag/mdx mice in a fibrin gel or in a saline solution (control). The use of 3 mg/ml fibrin gel for cell transplantation increased not only the survival of the cells as measured after 5 days but also the number of fibers expressing dystrophin after 21 days, compared to the control. Moreover, the fibrin gel was also compared to a prosurvival cocktail. The survival of the myoblasts at 5 days was increased in both conditions compared to the control but the efficacy of the prosurvival cocktail was not significantly higher than the fibrin gel.
INTRODUCTION
proliferate and differentiate as myoblasts, which subsequently activate myogenic differentiation to fuse among themselves to form new myofibers (17, 33) . These Duchenne muscular dystrophy (DMD) is the most common genetic muscle disorder in children. The inci-myoblasts can be proliferated in culture and transplanted in muscles to fuse together and form new fibers or to dence is about 1/3,500 live male births and currently there is no efficient treatment (15) . The cause of DMD fuse with host myofibers, introducing in these hybrid fibers nuclei able to produce dystrophin in the case of is a severe deficiency of dystrophin, a major component of the dystrophin-glycoprotein complex in muscle fibers, DMD. Unfortunately, transplanted proliferating myogenic cells undergo rapid and massive cell death within responsible for the maintenance of sarcolemma integrity (10). Following the loss of a functional dystrophin pro-a few days following implantation into skeletal muscles, as a result of cell dissociation, trophic factor withdrawal, tein, the muscles of DMD patients progressively degenerate as a result of continuous myofiber necrosis, leading oxidative stress, excitotoxicity, hypoxia, and possibly anoikis. Anoikis is a type of apoptosis that is triggered to death into the second/third decade of the patient's life (17, 31) .
by detachment from the extracellular matrix and neighboring cells (18, 20) . Some studies pointed out that apo-Cell transplantation offers hope for a future treatment of DMD. Different stem cell populations were proposed ptosis, as well as anoikis, could be implicated in cell death after cell transplantation in muscles and in myo-for transplantation such as satellite cells, myogenic progenitors, muscle-derived stem cells, and bone marrow cardium (13, 21, 32, 34) .
The goal of the present study is to test a biomaterial, stem cells (27, 35) . Satellite cells are muscle-committed stem cells that lie between the basement membrane and which can serve as support for cell transplantation, providing a matrix around the cells to avoid anoikis during the sarcolemma. Satellite cells are quiescent, but under specific stimuli such as myofiber necrosis, some of them the first days after engraftment and that could disappear permitting the fusion of the cells with the surrounding by 50% compared to the control muscles (myoblasts injected in saline). myofibers. Despite the fact that natural hydrogels (i.e., collagen, Matrigel, fibrin) could present batch-to-batch MATERIALS AND METHODS variability, or some difficulties in chemical manipula-In Vitro Studies tion, they still appear to be superior to synthetic hydrogels for muscle tissue engineering, primarily due to the Reagents. Fetal bovine serum (FBS), Trizol, trypsin, higher density of cell adhesion sites required for the 3D and penicillin/streptomycin were obtained from Invitrogen cell spreading (8) .
(Burlington, Canada). Hank's balanced salt solution Fibrin is a natural biomaterial used in tissue engineer-(HBSS), collagenase, XTT (2,3-bis[2methoxy-4-nitro-5ing resulting from the interaction of fibrinogen monosulfophenyl]-2H-tetrazolium-5-carboxyanilide inner salt) mers and thrombin. Exposure of fibrinogen monomers assay, phenazine methosulfate, human fibrinogen, human to thrombin results in conversion of fibrinogen to fibrin, thrombin, phenol/chloroform/isoamyl alcohol, and which polymerizes to form a fibrin mesh, by mechasodium citrate were purchased from Sigma Aldrich nisms similar to those involved in normal clotting in (Oakville, Ontario, Canada). Proteinase K was purchased vivo (30). As a biological material, fibrin has some from Novagen (Gibbstown, NJ, USA). The [methyl-1 4C] remarkable advantages over other synthetic materials: thymidine was purchased from PerkinElmer (Boston, excellent physiological activities, selective cell adhe-MA, USA). DNaseI, Superscript Reverse Transcriptsion, mechanical properties similar to natural tissues, ase, and DTT (dithiothreitol) were obtained from Inviand biodegradability. One advantage is its rapid degratrogen (Burlinton, Canada) and the random primers, Go dation in vivo (1). Fibrin gel is a biomaterial, easy to Taq, oligo(dT) 15 primer, RNasin from Promega (WI, form and use, controlled by the composition of fibrino-USA). Aprotinin (Trasylol) was purchased from Bayer gen and thrombin, and which could contain and progres-Inc. (Toronto, Canada) and basic fibroblast growth facsively release growth factors. Moreover, fibrin gel can tor (bFGF) from Gibco (Burlington, Canada). be injected and molded in situ to fill a tissular defect.
Cell Culture. Myoblasts were grown from a muscle The time of degradation can be increased by the presbiopsy obtained from a 23-year-old man (a cadaveric ence of aprotinin in the fibrin gel (5,25). Moreover, organ donor) following informed consent of the family some articles demonstrated that fibrin enhanced angioand approval by the Human Ethic Committee of the genesis in the biomaterial, which is an important limit-Centre Hospitalier de l'Université Laval's Research ing factor in tissue engineering (2). Fibrin gel is still Center (CRCHUL). Human myoblasts were obtained used in muscle tissue engineering. One study reported after enzymatic digestion of the human muscle sample that a defect was created in a rat muscle and filled with with collagenase (2%) in HBSS for 45 min at 37.5°C. myoblasts in a fibrin gel (5). The fibrin gel was formed The cells were then cultured at 37°C in a humidified in situ and muscle regeneration was observed after 12 atmosphere with 5% CO 2 in proliferating medium MB1 weeks. Moreover, fibrin gel was also incorporated in a (HyClone MB-1 Medium, HyClone Laboratories, Inc., silicone chamber for the culture of cardiomyocytes for Logan, UT, USA) supplemented with 15% FBS, 10 ng/ myocardial engineering (9) . Huang et al. used fibrin gel ml of bFGF, and 1% penicillin/streptomycin. Cells were to create an engineered self-organizing 3D skeletal musused between passages 2 and 4 (6, 12, 14) . cle (24). This allowed the myoblasts to fuse into myo-3D Culture in Fibrin Gel. Different solutions of tubes before the contraction of the gel. The gel can be human fibrinogen (3, 20, and 50 mg/ml) were made and maintained in culture 6 weeks. This model is interesting mixed with dispersed cells at a density of 200,000 cells/ to understand the importance of electrical activity, horml, and a volume of 500 µl was placed in each well of monal signals and mechanical inputs for the comprehena 24-well plate. Fibrinogen solution was mixed with sion of the development of skeletal muscle (24).
human thrombin (50 U/ml) at a ratio of 0.03:1 (v/v) to In the present study, the fibrin gel was used as a vecfibrin. Culture medium was introduced on the top of the tor for human myoblast transplantation in mice, trying gel. Aprotinin (50 U/ml), an antifibrinolytic agent, was to avoid the cell death through anoikis. The cell survival added in culture medium to maintain the fibrin gel integwas estimated with and without the fibrin gel and was rity during the incubation period (19). compared to that obtained with a prosurvival cocktail (PSC). This PSC enhanced function of infarcted rat heart Comparison Between Monolayer, Fibrin Coating, and 3D Culture. Myoblasts were cultured in six-well by improving graft survival of cardiomyocytes derived from human embryonic stem cells (28) . The use of 3 plates for monolayer (on plastic) and fibrin coating. The fibrin coating was made by polymerizing fibrin gel mg/ml fibrin gel for cell transplantation enhanced both the survival of the transplanted cells by 30%, and also (same conditions as below, 3 mg/ml fibrinogen) into the well before adding the cells. Then 100,000 cells were the number of myofibers expressing human dystrophin added into each well to be compared with the fibrin gel medium without aprotinin. At different times (days 0, 1, 3, 5, and 7), the gels were recovered, put on an absorb-also containing 100,000 cells. The cells were cultured 7 days in MB1 supplemented with aprotinin.
ing paper to eliminate residual medium, and then put into tubes to determine their wet weighs. The weight Proliferation. XTT assay was performed according was expressed as a percentage of lost weight. to the manufacturer's procedure (TOX2, Sigma-Aldrich Canada Ltd., Oakville, Ontario, Canada). Briefly, the In Vivo Studies cells were washed twice with HBSS. A mixture of 1 mg/ml XTT solution containing 1.5 mg/ml phenazine Cell Transplantation. The transplantations were done methosulfate solution was added to each well and incuin 2-month-old Rag/mdx mice produced in our animal bated for 3 h at 37°C in an incubator with 5% CO 2 .
facilities by crossing mdx/mdx mice (a DMD model due Optical densities were then determined in a fluorometer to a mutation leading to dystrophin deficiency) with (Spectra Max 340Pe molecular Devices, Sunnyvale, CA, >Rag −/− mice (an immunodeficient mouse that accepts USA) set at 450 nm absorbance and values were subhuman grafts). Mice were maintained under pathogentracted from the blank values. To estimate the number free conditions. All the experiments with mice were conof cells present in the fibrin gel, a standard curve was ducted after approval by the CRCHUL Animal Care made in the same conditions with increasing number Committee and in agreement with the guidelines of the of cells for each fibrin condition. The percentage of Canadian Council for Animal Care. proliferation was then used to compare the different The tibialis anterior muscles (TA) of recipient mice culture conditions.
were used for the implantation of 500,000 human male myoblasts per muscle. Briefly, the animals were under Gene Expression. The total RNA was extracted anesthesia with Isoflurane USP (Abbott Laboratories, using Trizol reagent from the myoblasts cultured on Montreal, Canada). The skin was opened to expose the monolayer, on fibrin coating and into a fibrin gel. First-TA, and the myoblasts, resuspended in 10 µl of HBSS, strand cDNAs were synthesized using 1 µg total RNA were slowly injected obliquely using a glass micropiwith the oligo(dt) primer and Superscript III reverse pette (Drummond Scientific Co., Broomall, PA, USA) transcriptase. Polymerase chain reaction (PCR) was perinto 7-12 sites of the TA (7) . The skin was closed with formed with 1 µg of the cDNA solution using the primabsorbable sutures. ers specific for glyceraldehyde 3-phosphate dehydrogenase (GAPDH, as reference gene), myogenic differentiation Graft Conditions. Cells were resuspended in HBSS (MyoD), myogenin, and myosin heavy chain 2 (MyHC).
as previously described or in other conditions described The annealing temperatures and the numbers of cycles below. In fibrin gel, the cells were mixed with the fibrinof PCR are presented in the Table 1 . PCR products were ogen solution and a thrombin solution was added just then separated by electrophoresis in 1% agarose gels and before the graft to obtain a 3, 20, or 50 mg/ml fibrin were stained with ethidium bromide. A picture of the gel in situ. A Pro-Survival Cocktail (PSC), described by gel was obtained with the GelDoc program (BioRad) Laflamme et al. in 2007 (28) , was also tested. The PSC under UV light.
includes: 1) Matrigel to prevent anoikis, 2) a cell-permeant peptide from Bcl-XL (B-cell lymphoma-extra large) Degradation Time. Gels of 3, 20, and 50 mg/ml of fibrin containing 100,000 cells were made, as described to block mitochondrial death pathways, 3) cyclosporine A to attenuate cyclophilin D-dependent mitochondrial above, in 24-well plates. The cells were cultured in pathways, 4) pinacidil, a compound that opens ATP-h), followed by an anti-mouse Alexa 488 (Invitrogen) (1:300, 30 min). Dystrophin and lamin A/C staining dependent K + channels to mimic ischemic preconditioning, 5) insulin growth factor -1 (IGF-1) to activate Akt were observed on PBS-glycerol-mounted slides under an ultraviolet lamp microscope using specific filters (510-pathways, and 6) ZVAD-fmk, a caspase inhibitor. Matrigel was also tested alone.
560 and 450-490, respectively). The highest number of dystrophin-positive fibers was counted for each muscle.
Three separate experiments of n ≥ 5 were made for this Cell Death Assay at 5 Days. To quantify the in vivo cell mortality, myoblasts were radiolabeled by culturing study. To pool the three different experiments, results were expressed as a percentage of dystrophin-positive them 48 h in growth medium containing 0.25 µCi/ml [methyl-14 C]thymidine (50 mCi/mmol) before the trans-fibers compared to the number of dystrophin-positive fibers obtained in the control group (HBSS). plantation. Radiolabeled cells (500,000 cells) were injected throughout the TA using a glass micropipette as
Statistical Analysis previously described. The muscles were removed at days 0 and 5 after cell transplantation, snap frozen in Statistical significance was determined by Kruskalliquid nitrogen, and stored at −80°C. DNA was extracted
Wallis chi-square test. Differences were considered to from transplanted TAs. Briefly, muscles were minced be significant at p ≤ 0.05 (*) and p ≤ 0.01 (**). The and incubated with 50 µl of proteinase K (10 mg/ml) at number of points or animals used for each study is indi-56°C until the solution became clear. Digested muscles cated in the figure legends. were then mixed with 500 µl of a solution of phenol/ RESULTS chloroform/isoamyl alcohol (25:24:1) and centrifuged 3 min at 13,000 rpm. The upper solution was recovered
In Vitro Studies and mixed with the same volume of chloroform and cen-Effect of the Concentration of the Fibrin Gel on trifuged again. The upper solution was recovered and 25
Myoblast Proliferation. Myoblast metabolism was deterµl of 3 M citrate sodium was added before the addition mined with a XTT assay as an indicator of cell proliferaof 1 ml of 100% ethanol. After centrifugation 8 min at tion. The cells were cultured in different fibrin gel 13,000 rpm, the pellets were washed in 70% alcohol concentrations (i.e., 3, 20, and 50 mg/ml) during 7 days before another centrifugation. The pellets were then in the presence of aprotinin. The optical density (OD), dried before the suspension of the DNA in 100 µl sterile corresponding to the metabolism of the cells at each water. The amount of radiolabel within each TA was time point and gel concentration, is shown in Figure 1A . measured on DNA extracts using liquid scintillation
The myoblasts cultured in the 3 mg/ml fibrin gel were counter (Mod. Wallac 1409, Woodbridge, Ontario, Canmetabolically the most active during all the culture time, ada). The primary data (dpm) were given for day 0 and followed by the cells into the 20 mg/ml fibrin gel and day 5 as well as the amount of residual radioactivity at the cells with the lowest metabolic activity were those day 5 expressed as a percentage compared to day 0.
included in the 50 mg/ml fibrin gel. The ODs were then converted as number of cells Human Dystrophin Detection (Graft Success at 21 through a standard curve made for each fibrin condition.
Days Posttransplantation). After transplantation of the
The results were expressed as a percentage of cells comcells in the different conditions mentioned above, the pared to day 1 (Fig. 1B) . At day 3, the number of cells muscles were then recovered at 21 days after the surwas not significantly increased compared to day 1. At 7 gery. Cryosections were made for an immunohistochemdays, the number of cells increased 3.7 times in 3 mg/ istry against the dystrophin. The sections were first ml fibrin gel, 3.2 times in 20 mg/ml fibrin gel, and 2.5 washed with PBS. Nonspecific binding sites were times in the 50 mg/ml gel compared to the day 1. Moreblocked by incubating the cryostat sections with PBS over, the increases observed in the 3 and 20 mg/ml were containing 10% FBS, 10% goat serum, and 2% bovine significantly higher than that observed in 50 mg/ml serum albumin (BSA) for 30 min. Human dystrophin fibrin gel. These results showed that the myoblasts prowas detected with an anti-human dystrophin antibody liferated more at lower fibrin densities. (MANDYS104; MRIC Biochemistry Group, Wrexham, UK) (1:50 for 1 h), followed by a biotinylated anti-Comparison Between Monolayer, Fibrin Coating, and Fibrin Gel. Myoblasts were cultured on plastic mouse antibody (DAKO, Copenhagen, Denmark) (1:200 for 30 min) and streptavidin-Cy3 (Sigma-Aldrich) (1:
(monolayer condition), on a fibrin coating, or in a fibrin gel. Cell proliferation was quantified by XTT assay, as 500 for 30 min). Sections were washed three times with PBS after each antibody incubation. The sections were described above, after 7 days of culture in a medium containing aprotinin to maintain the gel. The results blocked again for the second detection. Human nuclei were detected using mouse anti-human lamin A/C anti-were expressed as a percentage of proliferation compared to day 1. After 7 days of culture, the number of body (Vector Laboratory, Burlingame, CA) (1:100 for 1 Figure 1 . Human myoblasts were cultured in fibrin gel at different concentrations of fibrinogen (3, 20, and 50 mg/ml). The metabolism of the cells (optical density values) into the gels was determined by a XTT (2,3-bis[2methoxy-4-nitro-5-sulfophenyl]-2H-tetrazolium-5-carboxyanilide inner salt assay) (A). According to a standard curve, the number of cells was then estimated at 1, 3, and 7 days of culture and expressed as a percentage of cells relative to 100% at day 1 (B) (n ≥ 8; SD; *p ≤ 0.05).
cells increased by 8.7-fold in monolayer and on a fibrin
Time Rate of Degradation of the Different Fibrin Gels. Cells were cultured in the different fibrin gels coating ( Fig. 2A) . In a fibrin gel, the proliferation was significantly lower than in these two previous condi-under different concentrations of fibrinogen (3, 20, and 50 mg/ml) during 7 days and the wet weight of the gels tions, as the number of cells increased only by 3.7-fold.
Myoblast differentiation was also analyzed by RT-with the included cells was measured every other day during 7 days of culture ( Fig. 3) . At day 3, only the 3 PCR and compared at day 7 between the three culture conditions (Fig. 2B ). Myoblasts cultured on classic mg/ml gel had a weight significantly lower than the weight at day 0 and was significantly decreased com-monolayer showed a higher MyoD expression compared to the cells cultured on fibrin or inside a fibrin gel.
pared to the two other gels. The 3 mg/ml fibrin gel continued to diminish at 5 and 7 days of culture, at which Moreover, in the presence of fibrin (coating or gel), the expression of myogenin was increased compared to the time only 5% of the initial weight was observed. The 20 and 50 mg/ml gels were the more stable, being signifi-monolayer condition. MyHC expression was only observed in the fibrin gel correlating with the highest cantly different from the day 0 weights only after 7 days of culture; the weights were then respectively 26% and myogenin expression in that situation. 73% of the weight at day 0. Therefore, the 50 mg/ml found after 5 days was only 5%. The Matrigel cocktail gave the highest percentage of residual radioactivity at gel was the most stable in culture. Indeed, the 3 mg/ml gel was almost completely degraded compared to the day 5. Only two conditions were significantly different from the control, the fibrin at 3 mg/ml and the Matrigel other two gels at day 7. cocktail, with 7.3% and 8.7% of radioactivity, respec-In Vivo Studies tively. However, there was no significant difference between these two groups. This experiment showed that Cell Survival 5 Days After Transplantation in Fibrin Gels of Different Concentrations. Radiolabeled cells using the fibrin gel alone increased myoblast survival as well as the PSC. were transplanted in mouse muscles that were recovered either at the transplantation day or 5 days later. The results were expressed as primary data (Fig. 4A) 
and as
Graft Success in Fibrin Gel. Several myofibers expressing human dystrophin were detected in the percentage of residual [ 14 C]thymidine at 5 days compared to the day of the transplantation (Fig. 4B) . These muscles recovered 21 days after human myoblast transplantation ( Fig. 5A, B) . The maximum number of dys-cells were grafted resuspended in HBSS or trapped in fibrin gels at different concentrations (3, 20, and 50 mg/ trophin-positive fibers in a given complete cross section was determined for each muscle. Three experiments ml). Only the 3 mg/ml fibrin gel was significantly higher than the control. A PSC has been previously reported to were made for this study and the number of dystrophinpositive fibers was reported for each experiment (Fig. increase the survival of cardiomyocytes (28) . This PSC contains Matrigel (Matrigel cocktail), and therefore 5C). For each experiment the average number of dystrophin-positive fibers was higher in the 3 mg/ml fibrin Matrigel alone was also tested. When the cells were transplanted in HBSS, the percentage of residual 14 C condition compared to the control. In order to have a global comparison of the results, the number of dys-ml fibrin gel. Our results with human primary myoblasts agree with those reported by Boontheekul et al. using a trophin-positive fibers in the control was expressed as 100% and the amount of dystrophin-positive fibers in mouse myoblast line (11) . Boontheekul et al. compared C 2 C 12 and primary myoblasts in 3D alginate gel from the fibrin gel-grafted muscles was estimated compared to this control. We found a significant increase (54%) in different stiffness (11) . They found that, when the C 2 C 12 cells were seeded into the gel, their proliferation was the 3 mg/ml fibrin gel condition (Fig. 5D ). The human nuclei were also observed in the same cryosections by increased in slowly degrading and stiffest gel. On the contrary, when the primary myoblasts were cultured in fluorescent immunolabeling for human lamin A/C. This allows visualizing the location of the human nuclei rela-a stiffer gel, they proliferated less than in a degradable gel. They concluded that results obtained with the C 2 C 12 tive to the human dystrophin-positive fibers. The human nuclei were all located into dystrophin-positive myofib-cell line may not be predictive of the response of primary myoblasts to environmental cues. In another study, ers (results not shown). This observation confirmed that the transplanted cells had fused with the damaged myo-myoblasts were cultured 7 days in fibrin glue containing 100 mg/ml fibrinogen. These authors observed a great fibers. In the two groups, we observed dystrophin-positive fibers of different sizes. The small fibers could proliferation of the cells during the culture, which seemed to be higher than in our study for the 50 mg/ml correspond to the fusion of transplanted cells exclusively among themselves to form new myofibers.
fibrin gel. However, no estimation of proliferation was made and the myoblasts were cultured at higher concen-DISCUSSION tration (200,000 cells in 150 µl of the fibrin glue) (16) . Our next step was to compare the culture of human In the present study, different concentrations of fibrin gel were used for the culture of human myoblasts. We myoblasts on plastic monolayer, on a fibrin gel or inside a fibrin gel. The proliferation of the cells was the same observed that the stiffer the gel, the lower was the cell OD detected by a XTT assay. Indeed, the OD was dif-in both monolayer conditions, which was higher than in the 3D culture. In this last condition, the differentiation ferent for each condition even at day 1. However, for each fibrin gel concentration, the OD increased at day 7 of the cells was earlier engaged. This process started with myoblasts, which are proliferative MyoD-and compared to day 1.
We also found that the stiffness of the gel influenced Myf5-positive cells. These proliferating myoblasts must withdraw from the cell cycle to become terminally dif-the cell proliferation. We found a 3.7-fold increase in the cell number between 1 and 7 days of culture in 3 ferentiated myocytes that express late myogenic regulatory factors (MRFs), myogenin, and MRF4. The cells mg/ml fibrin, and only a 2.5-fold increase for the 50 mg/ subsequently express muscle proteins such as MyHC by changing the proliferating culture medium for a differentiation medium with no FBS or low percentage of and creatine kinase, and fuse to form multinucleated myofibers (11) . The fibrin gel culture at 7 days not only FBS or horse serum (8, 13) . Aprotinin is used in culture medium to prevent the showed the highest expression of myogenin but it was the only condition in which MyHC expression was degradation of the gel by the cells. The degradation process of the gel was observed in our study by culturing detected. Similar results were observed by Bian et al., in a different culture condition than ours (i.e., 3% horse the cells without aprotinin and expressed as a gel weight loss compared to day 0. The more a gel is stiff, the less serum) (8) . Fusion of myoblasts is frequently induced the cells will degrade it. At 7 days, the 50 mg/ml gel still present 2 days after the transplantation but, 2 weeks later, the fibrin matrix was completely dissolved (5). was still at 72% of the initial weight. It is known that as the concentration of fibrinogen or thrombin increases in The degradation rate was not studied in vivo in our experiments; the microinjections consisted of distribut-a fibrin gel, its degradation becomes slow (25) . In another study, cardiac cells were plated on a fibrin gel ing 10 µl of the fibrin gel into 7-12 injection sites, which correspond to around 1 µl per site. We can only to form a bioengineered heart muscle. These authors added 200 µl of 20 mg/ml fibrinogen to a solution of suppose that in this condition the degradation time would be very fast. 500 µl culture medium containing thrombin, which corresponds to a 5.7 mg/ml final gel (700 µl). One million
In our present study, the fibrin gel seems to be present in the muscle long enough to help reduce slightly cells were plated on this fibrin gel and they found that the gel was degraded within 2 weeks (23) . The gel cre-the early cell death. The survival of transplanted cells was increased by 43% in a fibrin gel compared to the ated by intracardiac injection of a mixture of 500,000 mesenchymal stem cells into 150 µl of fibrin glue at 20 control. Christmann et al. used fibrin glue with a solution of 100 mg/ml fibrinogen. The commercial fibrin mg/ml was still observed 10 days after injection in another group (30). Finally, 1 ml of a fibrin gel at 10 glue also contains aprotinin, plasminogen, plasmafibronectin, and factor VIII. They injected 5,000,000 myoblasts mg/ml containing 500,000 primary rat myoblasts was injected in a muscle defect. The presence of fibrin was in 50 µl fibrin glue into infarcted myocardium. After 5 weeks, they found that the presence of fibrin glue 32). Since the radiolabel is lost by the dead cells and divided among proliferating cells, it can only reflect cell increases angiogenesis and the grafted cell survival and doubled the percentage of covered area with the grafted death but not cell proliferation (3, 32) . That means that there is probably more than 7% of living cells in the myoblasts (16) . Several approaches have been investigated to increase cell survival or long-term transplanta-fibrin group. In spite of the fact that the reduction of the early cell death obtained with the fibrin gel is small from tion success, among them the introduction of vascular endothelial growth factor (VEGF) through electropora-a clinical point of view, the present results are encouraging to progress in testing biomaterials and new prosur-tion of a plasmid (12) , the pretreatment of cells with diazoxide or bFGF (22, 26, 29) , or a coinjection of Matri-vival cocktails to improve the success of myoblast transplantation for potential future clinical applications. gel containing bFGF (36) . These are complex approaches leading to gains in survival ranging from CONCLUSION 30% to 200% increases. Concerning the graft success, Fibrin gel is a biocompatible material and has gained an increase from 30% to 400% was found in different FDA approval for human use as sealant (with around experiments. In these studies, the cells were transfected 100 mg/ml fibrinogen solution). Unlike xenogenic gelawith a lentivirus containing VEGF (12) or human follistin or collagen, which may induce inflammatory and tatin (7) , or pretreated with bFGF (26) . In our case, only immune responses, fibrin gel can avoid the potential risk the cells transplanted in a fibrin gel, without any genetic of a foreign body reaction when produced from the modifications or growths factors supplementation, patient own blood. Fibrin gel could be easily implantshowed an increase in the number of positive fibers of able by injections through a syringe. This would obviate more than 50%. Compared to a saline solution, the use open surgery for treatment and therefore reduce the of a biomaterial should improve the maintaining of the patient pain. Fibrin gel is also degraded enzymatically cells into the muscle, which would also explain the (25) . Moreover, the use of fibrin gel in myoblast transincreased number of dystrophin-positive fibers. Howplantation increased not only the survival of the transever, one article from Beauchamp et al. demonstrates planted cell at 5 days after the graft but also the number that the incorporation of the donor cells within a fibrin of dystrophin-positive fibers still present 21 days after clot did not prevent the loss of a majority of the transthe graft. Fibrin has the additional advantage that it planted myoblasts, compared to a saline solution, during binds growth factors, such as bFGF, which augment the first 2 days after myoblast transplantation (4). myogenesis (27) . Therefore, it will be interesting to mix It is difficult to compare our results with those the fibrin gel with growth factors or other compounds to obtained by other teams because of the differences ameliorate the survival and graft success by releasing between the types of cells transplanted, including the active molecule during the degradation of the gel. myoblasts from different species (human and mouse) and different ages (neonatal and adult cells). Moreover,
